Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Medicine for treating children dermatosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for skin diseases and pharmaceuticals, applied in the field of medicine, can solve the problems of toxic and side effects of western medicine, and achieve clear curative effect and good safety
Inactive Publication Date: 2014-02-05
郑海雁
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although it is simple and convenient to use western medicine for external use ointment at present, due to the relatively large toxic and side effects of western medicine, many adverse reactions often occur when it is used in children
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
experiment example
[0013] 1. Clinical data
[0014] Diagnostic criteria for children with urticaria: episodic skin sticky flushing or wheals, wheals of different shapes, sizes, pale or bright red, sometimes disappearing, consciously severe itching, a few accompanied by fever.
[0015] Children with urticaria were collected and divided into two groups, and 70 cases with relatively complete observation data after treatment were analyzed. The treatment group included 36 cases, including 18 males, aged from 7 months to 12 years old, with an average of 4.3 years old. There were 18 females, aged from 9 months to 10 years old, with an average of 4.9 years old. The control group consisted of 34 cases, including 17 males, aged 5 months to 11 years, with an average of 4.1 years old. 17 females, aged 5 months to 10 years, with an average of 4.3 years.
[0016] 2. Treatment
[0017] 2.1 The treatment group was treated with the decoction prepared in the embodiment, 2 times a day, 50 milliliters were take...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a medicine for treating children dermatosis. The medicine is prepared from the following substances in percentage by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of balloon flower, 15-25 parts of angelica dahurica, 5-15 parts of inula britannica chinensis, 10-30 parts of seed of cowherb, 1-15 parts of fibraurea recisa, 10-20 parts of radix sileris, 15-30 parts of Chinese ephedra, 20-30 parts of terminaliae billericae, 1-20 parts of morinda root, 1-20 parts of cynanchum atratum, 10-25 parts of trichosanthes, 10-30 parts of mustard seed, 1-20 parts of oil orange, 15-20 parts of murraya jasminorage, 10-20 parts of eucommia bark, 15-20 parts of Japanese inula herb, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of round cardamom, 5-15 parts of aleppo avens, 1-20 parts of rice sprout, 15-25 parts of dahurian rhododendron leaf, 15-25 parts of potentilla discolor, 10-20 parts of physalis alkekengi, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium herb, 1-20 parts of teasel root and 10-25 parts of rhododendron molle. All the components of the medicine for treating children dermatosis are natural materials. The medicine for treating children dermatosis has good security and definite curative effect and is suitable for large-scale popularization in clinical practice.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating children's skin diseases. Background technique [0002] Pediatric urticaria, also known as baby moss, occurs in spring and autumn, mostly in preschool children. It is a common and recurring allergic skin disease in children, usually accompanied by itching and other symptoms. Pruritus can make children restless, restless sleep, weight loss, and the condition is stubborn and lingering. Although it is simple and convenient to use western medicine for external use ointment drug treatment at present, because western medicine has relatively large toxic and side effects, it often produces a lot of adverse reactions when it is used in children. [0003] Urticaria in children is mostly caused by damp-heat evil impregnating the skin, which is caused by accumulation of blood in the blood collaterals and accumulation, or accumulation of damp-heat in the spleen and stomach. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.